Page last updated: 2024-10-23

bumetanide and Pneumonia

bumetanide has been researched along with Pneumonia in 2 studies

Pneumonia: Infection of the lung often accompanied by inflammation.

Research Excerpts

ExcerptRelevanceReference
"Moreover, hyperglycemia is known to induce NKCC1 expression via the activation of the serum-glucocorticoid kinase 1 (SGK1)-NKCC1 pathway."1.56Acute Hyperglycemia Aggravates Lung Injury via Activation of the SGK1-NKCC1 Pathway. ( Huang, KL; Lan, CC; Peng, CK; Wu, CP, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Wu, CP2
Huang, KL2
Peng, CK2
Lan, CC1
Shen, CH1
Lin, JY1
Chang, YL1
Wu, SY1

Other Studies

2 other studies available for bumetanide and Pneumonia

ArticleYear
Acute Hyperglycemia Aggravates Lung Injury via Activation of the SGK1-NKCC1 Pathway.
    International journal of molecular sciences, 2020, Jul-07, Volume: 21, Issue:13

    Topics: Acute Lung Injury; Alveolar Epithelial Cells; Animals; Bumetanide; Hyperglycemia; Immediate-Early Pr

2020
Inhibition of NKCC1 Modulates Alveolar Fluid Clearance and Inflammation in Ischemia-Reperfusion Lung Injury via TRAF6-Mediated Pathways.
    Frontiers in immunology, 2018, Volume: 9

    Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Bumetanide; Cell Line; Disease Models, Ani

2018